Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane E. Kiernan currently holds 93,949 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane E. Kiernan has been a net seller of TMCI stock. They have purchased $100.1K and sold $742.4K worth of shares.
Jane E. Kiernan's most recent insider trade was on May 19, 2026, when they sold 30,000 shares at $0.00 per share.
Jane E. Kiernan serves as Executive at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have executed 22 insider transactions totaling $842.4K over their tenure at the company.
Jane E. Kiernan holds the position of Executive at TREACE MEDICAL CONCEPTS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Jane E. Kiernan has shown a selling trading pattern, with $100.1K in total purchases and $742.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jane E. Kiernan was on Jul 5, 2022, when they sold $315.0K worth of AXNX shares. This transaction involved 5,250 shares at $60.00 per share.
Jane E. Kiernan currently owns 93,949 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane E. Kiernan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane E. Kiernan has 22 Form 4 filings on record as an insider at TREACE MEDICAL CONCEPTS, INC..
Set alerts for Jane E. Kiernan and 40,000+ other insiders.